ScoreWhy is Lushang Freda Pharmaceutical Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 7.45%
- The company has been able to generate a Return on Capital Employed (avg) of 7.45% signifying low profitability per unit of total capital (equity and debt)
2
The company is Net-Debt Free
- Poor long term growth as Net Sales has grown by an annual rate of -23.10% and Operating profit at -24.24% over the last 5 years
- The company is Net-Debt Free
- The company has been able to generate a Return on Equity (avg) of 9.84% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Net Sales has grown by an annual rate of -23.10% and Operating profit at -24.24% over the last 5 years
4
Flat results in Jun 26
- NET PROFIT(HY) At CNY 81.78 MM has Grown at -24.25%
- ROCE(HY) Lowest at 3.84%
5
With ROE of 4.40%, it has a expensive valuation with a 1.18 Price to Book Value
- Over the past year, while the stock has generated a return of -25.59%, its profits have fallen by -23%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Realty)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Lushang Freda Pharmaceutical Co., Ltd. for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
Lushang Freda Pharmaceutical Co., Ltd.
-26.41%
-1.06
24.39%
China Shanghai Composite
0.9%
0.22
14.72%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-23.10%
EBIT Growth (5y)
-24.24%
EBIT to Interest (avg)
8.03
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
19.89%
Dividend Payout Ratio
30.86%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
8.55%
ROE (avg)
9.84%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
27
Industry P/E
Price to Book Value
1.18
EV to EBIT
13.58
EV to EBITDA
7.96
EV to Capital Employed
1.50
EV to Sales
0.65
PEG Ratio
NA
Dividend Yield
1.21%
ROCE (Latest)
11.01%
ROE (Latest)
4.40%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend1What is working for the Company
RAW MATERIAL COST(Y)
Fallen by -11.26% (YoY
-6What is not working for the Company
NET PROFIT(HY)
At CNY 81.78 MM has Grown at -24.25%
ROCE(HY)
Lowest at 3.84%
Here's what is working for Lushang Freda Pharmaceutical Co., Ltd.
Raw Material Cost
Fallen by -11.26% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Lushang Freda Pharmaceutical Co., Ltd.
Net Profit
At CNY 81.78 MM has Grown at -24.25%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is negative
Net Profit (CNY MM)
Footer loading
